Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure

Anesthesia and Analgesia

Volumn 82, Issue 1, 1996, Pages 134-138

  Dhonneur, Gilles ^a   Rebaine, Chawky ^a   Slavov, Velislav ^a   Ruggier, Romanic ^a   De Chaubry, Véronique ^a   Duvaldestin, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; FLUNITRAZEPAM; ISOFLURANE; NEOSTIGMINE; NITROUS OXIDE; VECURONIUM;

ADULT; AGED; ANESTHESIA COMPLICATION; ANESTHESIA MECHANISM; ARTICLE; DRUG EFFECT; DRUG ELIMINATION; ENDOTRACHEAL INTUBATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; NEUROMUSCULAR BLOCKING; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AGED; ANESTHESIA, GENERAL; CHOLINESTERASE INHIBITORS; DRUG INTERACTIONS; HUMANS; KIDNEY; KIDNEY FAILURE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 0030029276     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199601000-00024     Document Type: Article

References (18)

1. Savarese JJ, Miller RD, Lien CA, Caldwell JE. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, ed. Anesthesia. New York: Churchill Livingstone, 1994:417-86.
2. Bartkowski RR. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine and edrophonium. Anesth Analg 1987;66:594-8.
3. Goldhill DR, Embree PB, Ali HH, et al. Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium. Anaesthesia 1988;43:443-6.
4. Kopman AF. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions. Anesthesiology 1986;65:572-8.
5. Gencarelli PJ, Miller RD. Antagonism of ORG NC45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine. Br J Anaesth 1982;54:53-6.
6. Lynam DP, Cronnelly R, Castagnoli KP, et al. The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure. Anesthesiology 1988;69:227-31.
7. Bonde J, Viby Mogensen J. Evoked reversal of neuromuscular block. In: Pollard BJ, ed. Applied neuromuscular pharmacology. Oxford: Oxford University Press, 1994:123-42.
8. O'Hara DA, Fragen RJ, Shanks CA. Reappearance of the train-of-four after neuromuscular blockade induced with tubocurarine, vecuronium or atracurium. Br J Anaesth 1986;58:1296-9.
9. Bevan DR, Donati F, Kopman AF. Reversal of neuromuscular blockade. Anesthesiology 1992;77:785-805.
10. Rupp SM, McChristian JW, Miller RD, et al. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium or vecuronium. Anesthesiology 1986;64:711-7.
11. Sheiner LB, Stanski DR, Vozeh S, et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979;25:358-71.
12. Fahey MR, Morris RB, Miller RD, et al. Pharmacokinetics of ORG NC 45 (Norcuron) in patients with and without renal failure. Br J Anaesth 1981;53:1049-52.
13. Bencini AF, Scaf AHJ, Sohn YJ, et al. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure. Anesth Analg 1986;65:245-51.
14. Cronnelly R, Stanski DR, Miller RD, et al. Renal function and the pharmacokinetics of neostigmine in anesthetized man. Anesthesiology 1979;51:222-6.
15. Bevan DR, Donati F, Gyasi H, et al. Vecuronium in renal failure. Can Anaesth Soc J 1984;31:491-6.
16. Baurain MJ, D'Hollander AA, Melot C, et al. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology 1991;74:474-8.
17. Slavov V, Khalil M, Merle JC, et al. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients. Br J Anaesth 1995;74:709-11.
18. Greenblatt DJ, Sellers EM, Shader RI. Drug disposition in old age. N Engl J Med 1982;306:1081-8.